See what your fund actually adds
Global X Genomics & Biotechnology ETF GNOM
Historical return decomposition and an investable replication portfolio, using data through 2026-10-09.
Fund and replication metrics
| Measure | GNOM | Replication |
|---|---|---|
| Annualized growth | -4.1% | 5.9% |
| Annualized volatility | 31.8% | 19.2% |
| Sharpe ratio | 0.03 | 0.39 |
| Maximum drawdown | 67.2% | 30.7% |
| Replication fit (R²) | 0.60 · Tracking error 20.0% | |
Replication portfolio
The published portfolio below is the investable basket used to model GNOM’s historical return behavior.
| Ticker | Building block | Weight |
|---|---|---|
| VBK | Small-Cap · Growth | 46.4% |
| IWC | Micro Cap | 32.1% |
| XLV | Sector · Healthcare | 21.5% |